Hepatoprotective effects of grape seed procyanidin B2 in rats with carbon tetrachloride-induced hepatic fibrosis

Alternative Therapies in Health and Medicine

Volumn 21, Issue , 2015, Pages 12-21

  Wang, Zhenli ^a,b   Zhang, Zemin ^c   Du, Ning ^c   Wang, Kai ^a   Li, Lei ^c  

^a SHANDONG UNIVERSITY   (China)

^b Qingdao Hospital for Infectious Disease   (China)

^c Department of Obstetrics and Gynecology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BIFLAVONOID; CARBON TETRACHLORIDE; CATECHIN; CYTOKINE; GRAPE SEED EXTRACT; PROANTHOCYANIDIN; PROCYANIDIN B2;

ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; LIVER; LIVER CIRRHOSIS; MALE; METABOLISM; OXIDATIVE STRESS; PLANT SEED; RAT; SPRAGUE DAWLEY RAT; VITIS;

ANIMALS; ANTIOXIDANTS; BIFLAVONOIDS; CARBON TETRACHLORIDE; CATECHIN; CYTOKINES; GRAPE SEED EXTRACT; LIVER; LIVER CIRRHOSIS; MALE; OXIDATIVE STRESS; PROANTHOCYANIDINS; RATS; RATS, SPRAGUE-DAWLEY; SEEDS; VITIS;

EID: 84942569619     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008;359(14):1486-1500.
2. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection [published online ahead of print July 30, 2014]. J Hepatol. 2014;61(1S):S45-S57. doi:10.1016/j.jhep.2014.07.027.
3. Elpek GO. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: an update. World J Gastroenterol. 2014;20(23):7260-7276.
4. Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425-456.
5. Czaja AJ. Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol. 2014;20(10):2515-2532.
6. Krithika R, Jyothilakshmi V, Verma RJ. Phyllanthin inhibits CCl4-mediated oxidative stress and hepatic fibrosis by down-regulating TNF-α/NF-κB and profibrotic factor TGF-β1 mediated inflammatory signaling [published online ahead of print May 9, 2014]. Toxicol Ind Health.
7. Wang X, Chen YX, Xu CF, Zhao GN, Huang YX, Wang QL. Relationship between tumor necrosis factor-alpha and liver fibrosis. World J Gastroenterol. 1998;4(1):18.
8. Tsukamoto H. Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res. 1999;23(5):911-916.
9. Li J, Qiu SJ, She WM, et al. Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis. PLoS One. 2012;7(6):e39307.
10. Tan Z, Qian X, Jiang R, et al. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol. 2013;191(4):1835-1844.
11. Sanchez-Valle V, Chavez-Tapia NC, Uribe M, Mendez-Sanchez N. Role of oxidative stress and molecular changes in liver fibrosis: a review. Curr Med Chem. 2012;19(28):4850-4860.
12. Zou YH, Yang Y, Li J, et al. Potential therapeutic effects of a traditional Chinese formulation, BJ-JN, on liver fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol. 2008;120(3):452-457.
13. Huang X, Wang X, Lv Y, Xu L, Lin J, Diao Y. Protection effect of kallistatin on carbon tetrachloride-induced liver fibrosis in rats via antioxidative stress. PLoS One. 2014;9(2):e88498.
14. Pereira RM, dos Santos RA, da Costa Dias FL, Teixeira MM, Simoes e Silva AC. Renin-angiotensin system in the pathogenesis of liver fibrosis. World J Gastroenterol. 2009;15(21):2579-2586.
15. Bataller R, Gabele E, Parsons CJ, et al. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology. 2005;41(5):1046-1055.
16. Paizis G, Gilbert RE, Cooper ME, et al. Effect of angiotensin II type 1 receptor on experimental hepatic fibrogenesis. J Hepatol. 2001;35(3):376-385.
17. Yang L, Bataller R, Dulyx J, et al. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. J Hepatol. 2005;43(2):317-323.
18. Xu T, Hui L, Juan YL, Min SG, Hua WT. Effects of moxibustion or acupoint therapy for the treatment of primary dysmenorrhea: a meta-analysis. Altern Ther Health Med. 2014;20(4):33-42.
19. Tan C, Chen W, Wu Y, Chen S. Chinese medicine for mental disorder and its applications in psychosomatic diseases. Altern Ther Health Med. 2013;19(1):59-69.
20. Lv J, Zhao Z, Chen Y, et al. The Chinese herbal decoction danggui buxue tang inhibits angiogenesis in a rat model of liver fibrosis. Evid Based Complement Alternat Med. 2012;2012:284963.
21. Zhao BX, Sun YB, Wang SQ, et al. Grape seed procyanidin reversal of p-glycoprotein associated multi-drug resistance via down- regulation of NF-κB and MAPK/ERK mediated YB-1 activity in A2780/T cells. PLoS One. 2013;8(8):e71071.
22. Fan H, Wang Y, Ren K, et al. Inhibitory effect and mechanism of procyanidin from vaccinium on isoprenaline-induced myocardial fibrosis in rats [in Chinese]. Zhongguo Zhong Yao Za Zhi. 2012;37(3):344-347.
23. Li BY, Li XL, Cai Q, et al. Induction of lactadherin mediates the apoptosis of endothelial cells in response to advanced glycation end products and protective effects of grape seed procyanidin B2 and resveratrol. Apoptosis. 2011;16(7):732-745.
24. Li XL, Li BY, Cheng M, et al. PIMT prevents the apoptosis of endothelial cells in response to glycated low density lipoproteins and protective effects of grape seed procyanidin B2. PLoS One. 2013;8(7):e69979.
25. Zhang Z, Li BY, Li XL, et al. Proteomic analysis of kidney and protective effects of grape seed procyanidin B2 in db/db mice indicate MFG-E8 as a key molecule in the development of diabetic nephropathy. Biochim Biophys Acta. 2013;1832(6):805-816.
26. Yu F, Li BY, Li XL, et al. Proteomic analysis of aorta and protective effects of grape seed procyanidin B2 in db/db mice reveal a critical role of milk fat globule epidermal growth factor-8 in diabetic arterial damage. PLoS One. 2012;7(12):e52541.
27. Cai Q, Li BY, Gao HQ, et al. Grape seed procyanidin b2 inhibits human aortic smooth muscle cell proliferation and migration induced by advanced glycation end products. Biosci Biotechnol Biochem. 2011;75(9):1692-1697.
28. Issa R, Zhou X, Constandinou CM, et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology. 2004;126(7):1795-1808.
29. Huang Y, Feng H, Kan T, et al. Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells. PLoS One. 2013;8(8):e73492.
30. Li CH, Pan LH, Yang ZW, Li CY, Xu WX. Preventive effect of Qianggan- Rongxian decoction on rat liver fibrosis. World J Gastroenterol. 2008;14(22):3569-3573.
31. Maeda K, Koda M, Matono T, et al. Preventive effects of ME3738 on hepatic fibrosis induced by bile duct ligation in rats. Hepatol Res. 2008;38(7):727-735.
32. Kim KH, Kim HC, Hwang MY, et al. The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis. Biochem Biophys Res Commun. 2006;343(4):1072-1078.
33. Su LJ, Chang CC, Yang CH, et al. Graptopetalum paraguayense ameliorates chemical-induced rat hepatic fibrosis in vivo and inactivates stellate cells and kupffer cells in vitro. PLoS One. 2013;8(1):e53988.
34. Ishikawa H, Takaki A, Tsuzaki R, et al. L-carnitine prevents progression of nonalcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway. PLoS One. 2014;9(7):e100627.
35. Dulundu E, Ozel Y, Topaloglu U, et al. Grape seed extract reduces oxidative stress and fibrosis in experimental biliary obstruction. J Gastroenterol Hepatol. 2007;22(6):885-892.
36. Shin MO, Moon JO. Effect of dietary supplementation of grape skin and seeds on liver fibrosis induced by dimethylnitrosamine in rats. Nutr Res Pract. 2010;4(5):369-374.
37. Zhang L, Mai M, Yuan Y, Wang L, Ma X. Anti-oxidation effects of grape seed proanthocyanidins on hepatic ischemia reperfusion injury in rats. J Xinjiang Med Univ. 2010;33(2):121-123.
38. Chang H, Jiang B. Effects of grape seed proanthocyanidin and casein peptide on the liver function and protein nutritional status in rats with radiation injury. JPEN J Parenter Enteral Nutr. 2005;12:162-164.
39. Li J, Li J, Li S, et al. Ameliorative effect of grape seed proanthocyanidin extract on thioacetamide-induced mouse hepatic fibrosis. Toxicol Lett. 2012;213(3):353-360.
40. Cameron GR, Karunaratne WA. Carbon tetrachloride cirrhosis in relation to liver regeneration. J Pathol. 1936;42(1):1-21.
41. Miyazaki T, Karube M, Matsuzaki Y, et al. Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis. J Hepatol. 2005;43(1):117-125.
42. Trebicka J, Hennenberg M, Odenthal M, et al. Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. J Hepatol. 2010;53(4):702-712.
43. Choi SS, Dieh AM. Epithelial-to-mesenchymal transitions in the liver. Hepatology. 2009;50(6):2007-2013.
44. Brenner DA. Molecular pathogenesis of liver fibrosis. Trans Am Clin Climatol Assoc. 2009;120:361-368.
45. Ishikawa S, Ikejima K, Yamagata H, et al. CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice. J Hepatol. 2011;54(6):1195-1204.
46. Kamari Y, Shaish A, Vax E, et al. Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol. 2011;55(5):1086-1094.
47. Toda K, Kumagai N, Kaneko F, et al. Pentoxifylline prevents pig serum-induced rat liver fibrosis by inhibiting interleukin-6 production. J Gastroenterol Hepatol. 2009;24(5):860-865.
48. Meng F, Wang K, Aoyama T, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology. 2012;143(3):765-776.e1-3.